Natalizumab Completed Phase N/A Trials for Relapsing Remitting Multiple Sclerosis (RRMS)

CompletedNot AvailableNot Available IdentifierTitleDrugs Disease Activity With Long Term Natalizumab Treatment Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab) Natalizumab (TYSABRI) Observational Program Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function